IP Library Patent Application 19053086
Patent Application
App. No. 19/053,086

BILIARY STENTS AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/053,086
Abstract

A tissue lumen stent is provided with a body having an elongated tubular configuration and a foreshortened configuration. In the foreshortened configuration, downstream and upstream ends of the body expand radially into downstream and upstream flange structures, leaving a generally cylindrical saddle region therebetween. In some embodiments, the flange structures are non-symmetrical with respect to one another. Systems and methods of using the stents are also disclosed.

Claims (22)

1 . A stent comprising a body having an elongated tubular configuration and a foreshortened configuration wherein a downstream end of the body expands into a downstream flange structure and an upstream end of the body expands into a flared flange structure, wherein a maximum outer diameter of the downstream flange structure is greater than twice a maximum axial length of the downstream flange structure, and wherein a portion of the flared flange structure increases in diameter and another portion of the flared flange structure decreases in diameter.

2 . The stent of claim 1 , wherein the downstream flange structure is a double-walled flange.

3 . The stent of claim 1 , wherein the flared flange structure comprises a larger maximum lateral dimension than that of the downstream flange structure.

4 . The stent of claim 1 , further comprising a saddle region between the downstream flange structure and flared flange structure.

5 . The stent of claim 4 , further comprising a covering or membrane over the saddle region and the downstream flange structure.

6 . The stent of claim 4 , further comprising a covering or membrane over the saddle region and the flared flange structure.

7 . The stent of claim 5 , wherein the flared flange structure is uncovered.

8 . The stent of claim 1 , wherein one or more of the downstream and flared flange structures have a pull-out force of greater than about 2.94N.

9 . A stent comprising a body having an elongated tubular configuration and a foreshortened configuration wherein a downstream end of the body expands into a downstream flange structure and an upstream end of the body expands into a flared flange structure leaving a saddle region therebetween, wherein an axial length of the flared flange structure is at least as long as an axial length of the saddle region.

10 . The stent of claim 9 , wherein the flared flange structure comprises a larger maximum lateral dimension than that of the downstream flange structure.

11 . The stent of claim 9 , wherein the downstream flange structure comprises a larger maximum axial width than the flared flange structure.

12 . The stent of claim 9 , further comprising a covering or membrane over the body of the stent.

13 . The stent of claim 12 , wherein the covering extends over the downstream flange structure.

14 . The stent of claim 12 , wherein the covering extends over the flared flange structure.

15 . The stent of claim 12 , wherein the flared flange structure is uncovered and the downstream flange structure is covered.

16 . A method of treating a patient, comprising:

accessing a biliary system of a patient with an endoscope; and

deploying, within the biliary system of the patient, a stent having a foreshortened configuration defining an upstream flared flange structure, a downstream flange structure and a cylindrical portion extending therebetween, wherein a maximum outer diameter of the downstream flange structure is greater than twice a maximum axial length of the downstream flange structure, and wherein a portion of the flared flange structure increases in diameter and another portion of the flared flange structure decreases in diameter.

17 . The method of claim 16 , wherein the stent contacts a lumen selected from the group consisting of the common bile duct, the pancreatic duct, and the hepatic duct.

18 . The stent of claim 1 , wherein a distal end of the flared flange structure includes an inward curl.

19 . The stent of claim 9 , wherein a distal end of the flared flange structure includes an inward curl.

20 . The method of claim 16 , wherein a distal end of the flared flange structure includes an inward curl.